Method and system for myocardial infarction repair
Patent Number: 6671558
Date of First Priority Issue: Friday November 7th, 1997
Date Issued: Tuesday December 30th, 2003
Assignee: Medtronic, Inc. (Minneapolis, MN)
Inventors: Soykan, Orhan (Shoreview, MN); Donovan, Maura G. (St. Paul, MN)
From Class: Use
Comments: No comments
This patent covers a method of preventing heart failure after a myocardial infarction through the administration of stem cells, together with a device that induces electrical signals. In some embodiments the stem cells are transfected with genetic material to modify functions (ie increased contractility: transfect with SERCA-2, increase angiogenesis: transfect with FGF, etc).
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.